Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (41-50 of 815) with videos related to

Pageof 82
Sort By:
British Journal of Cancer|October 1, 1982
The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair processR R Weichselbaum, J B Little
Nature Medicine|July 9, 2011
A downside to apoptosis in cancer therapy?Philip P Connell, Ralph R Weichselbaum
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2013
Small molecule derived from a natural product that mitigates radiation injuryPhilip P Connell, Ralph R Weichselbaum
Nature Cancer|February 5, 2022
Immunoradiotherapy goes club(bing)Ralph R Weichselbaum, Sean P Pitroda
Environmental Mutagenesis|January 1, 1985
Antipain-mediated suppression of sister chromatid exchanges induced by an inhibitor of poly (ADP-ribose) polymeraseJ L Schwartz, R R Weichselbaum
Nature Reviews. Clinical Oncology|May 17, 2019
Integrated molecular and clinical staging defines the spectrum of metastatic cancerSean P Pitroda, Ralph R Weichselbaum
JAMA Oncology|November 20, 2025
Radiotherapy Duality in Metastatic Disease-Inhibiting Seeding, Unmasking DormancySean P Pitroda, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumorsE E Vokes, R R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
Measurable impact: multimodality therapy of head and neck cancerE E Vokes, R R Weichselbaum
The New England Journal of Medicine|November 23, 2007
More on cetuximab in head and neck cancerLoren K Mell, Ralph R Weichselbaum
Pageof 82

Showing results (41-50 of 815) with videos related to

Sort By:
Pageof 82
British Journal of Cancer|October 1, 1982
The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair processR R Weichselbaum, J B Little
Nature Medicine|July 9, 2011
A downside to apoptosis in cancer therapy?Philip P Connell, Ralph R Weichselbaum
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2013
Small molecule derived from a natural product that mitigates radiation injuryPhilip P Connell, Ralph R Weichselbaum
Nature Cancer|February 5, 2022
Immunoradiotherapy goes club(bing)Ralph R Weichselbaum, Sean P Pitroda
Environmental Mutagenesis|January 1, 1985
Antipain-mediated suppression of sister chromatid exchanges induced by an inhibitor of poly (ADP-ribose) polymeraseJ L Schwartz, R R Weichselbaum
Nature Reviews. Clinical Oncology|May 17, 2019
Integrated molecular and clinical staging defines the spectrum of metastatic cancerSean P Pitroda, Ralph R Weichselbaum
JAMA Oncology|November 20, 2025
Radiotherapy Duality in Metastatic Disease-Inhibiting Seeding, Unmasking DormancySean P Pitroda, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumorsE E Vokes, R R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
Measurable impact: multimodality therapy of head and neck cancerE E Vokes, R R Weichselbaum
The New England Journal of Medicine|November 23, 2007
More on cetuximab in head and neck cancerLoren K Mell, Ralph R Weichselbaum
Pageof 82